STAAR Surgical's Q3 profit drops due to higher income taxes

STAAR Surgical

05/11/2025 21:36

Overview

STAAR Surgical Q3 net sales rise 6.9% yr/yr, driven by December China Shipment

Net income for Q3 falls to $8.9 mln, impacted by higher income taxes

Company repurchased 115,000 shares for $2 mln under buyback program

Outlook

Company did not provide specific guidance due to pending acquisition by Alcon Inc.

Result Drivers

DECEMBER CHINA SHIPMENT - Recognition of $25.9 mln from December China Shipment drove Q3 net sales increase

GROSS MARGIN IMPROVEMENT - Gross margin rose to 82.2% due to cost reductions and timing of sales recognition

INVENTORY MANAGEMENT IN CHINA - Lower new orders from China distributors due to leaner inventory management

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 EPS
$0.18
Q3 Net Income
$8.88 mln
Q3 Gross Margin
82.20%
Q3 Gross Profit
$77.88 mln
Q3 Operating Income
$18.49 mln


Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 9 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."

Wall Street's median 12-month price target for STAAR Surgical Co is $28.00, about 9.7% above its November 4 closing price of $25.28

Press Release: ID:nBwbYL5pZa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)